Arcturus Therapeutics Holdings (ARCT) Retained Earnings (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Retained Earnings data on file, last reported at -$541.6 million in Q1 2026.

• Quarterly Retained Earnings fell 17.0% year-over-year to -$541.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$541.6 million (down 17.0% YoY) and the FY2025 annual result came in at -$514.6 million, down 174.6% from the prior year.
• Retained Earnings retreated to -$541.6 million in Q1 2026, from -$514.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $710.0 million in Q3 2025 to a low of -$541.6 million in Q1 2026.
• A 5-year average of -$281.2 million and a median of -$398.7 million in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 287.49% — and 2025, when it plunged 174.6%.
• Tracing ARCT's Retained Earnings over 5 years: stood at -$338.1 million in 2022, then declined by 8.8% to -$367.9 million in 2023, then surged by 287.49% to $689.8 million in 2024, then sank by 174.6% to -$514.6 million in 2025, then slipped by 5.24% to -$541.6 million in 2026.
• The last three Retained Earnings figures came in at -$541.6 million (Q1 2026), -$514.6 million (Q4 2025), and $710.0 million (Q3 2025), per Business Quant data.